RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH
1 total filings · 0 classes · Active since Aug 2014
RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 36 (Insurance & Finance) with 1 filings. The WikiTrademarks Expansion Score is 3/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed August 28, 2026
Protect or track "RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 79155747 | RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH | Aug 29, 2014 | Pending | 036 Insurance & Finance 041 Education & Entertainment | Rising Tide Foundation for Clinical Cancer Research |
Weekly visibility reports showing how ChatGPT mentions RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH trademark portfolio
What trademarks does RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH hold?
RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 36 (Insurance & Finance), Class 41 (Education & Entertainment). The most recent filings are registered to Rising Tide Foundation for Clinical Cancer Research.
How many trademarks does RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH. The brand has been actively filing since August 2014. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH file most often?
RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH's most active class is NICE Class 36 (Insurance & Finance), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH trademark?
The most recent filings under the RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH mark are registered to Rising Tide Foundation for Clinical Cancer Research. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH expanding into new categories?
The current WikiTrademarks Expansion Score for RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH is 3 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH trademark filings?
Click the Watch Brand button at the top of this page to add RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH and help the next person researching it.